🧬 biology

IF2 aptamers allosterically impair bacterial translation initiation

This study reports the development and characterization of two DNA aptamers (Apt 311 and Apt 312) that allosterically inhibit bacterial translation initiation by binding to the essential factor IF2, thereby impeding initiator tRNA accommodation and subunit joining without affecting initial tRNA binding.

Original authors: Lesia Tello, Katherin Peñaranda, Ana Sanchez-Castro, Joaquin Rodriguez Trelles, Victor Barrenechea, Daria Vinogradova, Pablo Dans, Alena Paleskava, Andrey Konevega, Roberto Spurio, Pohl Milon

Published 2026-08-11

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Lesia Tello, Katherin Peñaranda, Ana Sanchez-Castro, Joaquin Rodriguez Trelles, Victor Barrenechea, Daria Vinogradova, Pablo Dans, Alena Paleskava, Andrey Konevega, Roberto Spurio, Pohl Milon

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine the inside of a living cell as a bustling, high-speed factory. The most important job in this factory is building proteins, the tiny machines that keep life running. To do this, the factory uses a massive, complex assembly line called the ribosome. But before the assembly line can start churning out products, it has to get set up perfectly. This setup phase is called "translation initiation." It's like a conductor getting a symphony orchestra ready: the musicians (ribosomal parts) must sit in the right seats, the sheet music (mRNA) must be placed correctly, and the very first musician (a special tRNA carrying the first amino acid) must take their spot. If this setup goes wrong, the whole song is ruined, and the factory stops working.

One of the most critical conductors in this process is a protein called IF2. Think of IF2 as the stage manager who ensures the first musician gets on stage and stays there until the rest of the band joins in. IF2 is a master of timing; it grabs the first musician, helps them find their seat, and then signals when the rest of the orchestra (the second half of the ribosome) can come in. Because this step is so vital, scientists have long looked for ways to stop it, hoping to find new antibiotics that can shut down bacterial factories without hurting human ones. However, finding a tool that specifically targets IF2's stage-managing duties without breaking the whole machine has been a tough challenge.

This is where a team of researchers from Peru, Russia, and Uruguay stepped in with a clever idea. Instead of using a traditional drug, they used "aptamers." If you imagine the ribosome as a lock, an aptamer is a custom-made key made of DNA that fits perfectly into a specific part of the lock. The scientists wanted to see if they could create a DNA key that would jam IF2's gears just enough to stop the show, but not break the machine entirely.

The researchers successfully created two DNA aptamers, which they named Apt 311 and Apt 312. They tested these against the bacterial IF2 protein and found that both were excellent at grabbing onto it. In fact, they stuck to IF2 with a very strong grip, binding tightly at concentrations as low as 0.3 to 0.5 micromolar. But the real magic wasn't just that they stuck; it was how they stuck.

To understand what happened next, the team used high-speed cameras (rapid kinetic assays) to watch the assembly line in action. They discovered that when Apt 311 latched onto IF2, it didn't stop the first musician from getting on stage. The initial arrival of the tRNA happened just fine. However, once the musician was there, they couldn't get settled into their seat. The aptamer seemed to freeze IF2 in a position where it couldn't help the musician "accommodate" or lock into place. It's as if the stage manager grabbed the musician's arm and held them in a half-standing position, preventing them from sitting down properly.

Because the musician couldn't get comfortable, the rest of the orchestra (the 50S subunit) couldn't join in effectively. The researchers observed that while the second half of the ribosome could still physically approach the first half, the final assembly of the complete machine was significantly reduced. The aptamer didn't block the door; it just made the stage manager so rigid that the whole process stalled.

The team also used computer simulations to peek at the molecular level. These models suggested that the aptamer binds to two specific regions of the IF2 protein (the G and C1 domains). By holding these two parts together, the aptamer stops IF2 from flexing and moving the way it needs to. Normally, IF2 acts like a flexible hinge, shifting its shape to help the tRNA settle in. The aptamer essentially "splints" this hinge, locking IF2 in a state where it can't do its job.

Interestingly, the study showed that this jamming works regardless of whether IF2 is holding onto a GTP molecule (its "energy" source) or not. The aptamer doesn't care what the protein is holding; it just locks the protein's shape. This suggests the aptamer works by changing the protein's flexibility rather than blocking a specific chemical reaction.

In the end, the paper concludes that Apt 311 and Apt 312 are powerful new tools. They don't just stop the process; they reveal exactly how IF2 moves and changes shape to do its job. By freezing IF2 in a specific pose, the scientists proved that the protein's ability to flex and shift is essential for the ribosome to start working. While these aptamers aren't yet a medicine, they offer a proof of concept: we can design tiny DNA strings to probe and control the most essential machinery of life, opening the door to understanding—and perhaps one day targeting—bacterial protein synthesis in very precise ways.

Technical Summary: IF2 Aptamers Allosterically Impair Bacterial Translation Initiation

Problem Statement
Translation initiation in prokaryotes is a rate-limiting, highly regulated step essential for protein synthesis, making it a prime target for antibiotic development. In bacteria, this process relies on three initiation factors (IF1, IF2, IF3), with IF2 being the only universally conserved guanosine-binding protein. IF2 orchestrates the recruitment of fMet–tRNAfMet to the 30S initiation complex (30S IC), accelerates 50S subunit joining, and drives initiator tRNA accommodation. Despite its critical role, no compounds currently exist that selectively halt IF2 functions specifically during the assembly of the initiation complex. While existing inhibitors like thiostrepton or evernimicin affect IF2 indirectly or act on the ribosome, and small molecules like lamotrigine bind IF2 but primarily compromise ribosomal biogenesis rather than initiation fidelity, there is a gap in tools that directly and specifically target IF2's functional dynamics during initiation.

Methodology
The study employed a multi-disciplinary approach combining SELEX (Systematic Evolution of Ligands by EXponential enrichment), biophysical characterization, rapid kinetic assays, and computational modeling.

Aptamer Selection: A 74-nucleotide single-stranded DNA library (40-nt random region flanked by constant regions) was subjected to SELEX against E. coli IF2 immobilized on beads. Four candidates (Apt 311–314) were enriched.
Binding Characterization: Specificity and affinity were assessed using Enzyme-Linked Oligonucleotide Assays (ELONA), Microscale Thermophoresis (MST), and stopped-flow FRET (Förster Resonance Energy Transfer). Binding was tested against IF2 isoforms (IF2α, IF2γ), other initiation factors (IF1, IF3), and unrelated proteins (BSA, 1F8).
Kinetic Analysis: Rapid kinetic assays using stopped-flow fluorescence and light scattering were performed to monitor:
- fMet–tRNAfMet binding and accommodation to the 30S pre-initiation complex (30S PIC).
- 50S subunit joining to form the 70S initiation complex (70S IC).
- Experiments were conducted under conditions of pre-formed 30S IC and concomitant binding of tRNA and 50S subunits.
Computational Modeling: In silico structural analysis involved predicting aptamer secondary/tertiary structures (VFold, AMBER MD), docking aptamers to IF2 (HDOCK), and superimposing these models onto ribosomal structures (30S PDB 5LMV; 70S PDB 3JCN, 7UNR, 7UNV) to assess steric clashes and interaction hotspots.
Mutational Analysis: Specific mutations (A16C, G20T) were introduced into the aptamer to validate predicted interaction interfaces.

Key Results

Selection and Specificity: Two DNA aptamers, Apt 311 and Apt 312, were identified with high specificity for IF2. They showed negligible binding to IF1, IF3, or unrelated proteins. Both bound IF2 isoforms (full-length IF2α and N-terminal truncated IF2γ) with comparable affinity, indicating the N1 domain is not involved in binding.
Affinity: MST analysis determined dissociation constants ( $K_d$ ) of $0.5 \pm 0.1$ µM for Apt 311 and $0.3 \pm 0.1$ µM for Apt 312.
Mechanism of Inhibition (30S IC Formation):
- Apt 311 did not perturb the initial binding of fMet–tRNAfMet to the 30S PIC (initial binding rate and amplitude remained unchanged).
- However, Apt 311 markedly impaired the subsequent accommodation of fMet–tRNAfMet into the P-site. The amplitude of the second kinetic phase (rearrangement/accommodation) was significantly reduced in a concentration-dependent manner ( $IC_{50} \approx 0.3$ µM).
- FRET data indicated that while IF2 still binds the 30S complex, the presence of the aptamer shifts the C2 domain of IF2 closer to IF1, suggesting a conformational change.
Mechanism of Inhibition (70S IC Formation):
- When 50S subunits were added to pre-formed 30S ICs, the rate of subunit joining was largely unaffected, but the yield (amplitude) of 70S IC formation was reduced.
- In concomitant binding assays (30S PIC + tRNA + 50S), Apt 311 caused a significant reduction in both the amplitude and rate of 70S assembly.
- Crucially, the inhibition of fMet–tRNAfMet accommodation (measured by BODIPY fluorescence) exceeded the inhibition of 50S joining (measured by light scattering). This indicates that the 50S subunit can physically join the 30S complex, but the initiator tRNA fails to reach its fully accommodated, productive state.
Structural Insights:
- Computational docking identified the G-domain and C1 domain of IF2 as interaction hotspots.
- The aptamer does not sterically occlude the GTPase active site or the tRNA binding site directly. Instead, it binds to the G and C1 domains, likely restricting the inter-domain flexibility required for the conformational transitions that couple GTP binding/hydrolysis to tRNA accommodation.
- Modeling suggests that while the aptamer-bound IF2 fits on the 30S subunit, it creates steric clashes with the 50S subunit in the context of the 70S ribosome, potentially limiting late inter-subunit rotations.
Nucleotide Independence: Binding affinity remained consistent regardless of whether IF2 was bound to GTP, GDP, GTPγS, or was in the apo state, suggesting the aptamer targets a structural feature independent of the nucleotide-bound conformation.

Significance and Claims
The authors claim that Apt 311 and Apt 312 represent the first reported aptamers that specifically target IF2 to impair bacterial translation initiation. The study establishes these molecules as tools that:

Allosterically inhibit IF2: They do not compete with tRNA or GTP but restrict the essential inter-domain dynamics of IF2 required for initiator tRNA accommodation and the transition from 30S to 70S ICs.
Uncouple initiation steps: They demonstrate that 50S subunit joining can occur even when tRNA accommodation is blocked, leading to non-productive complexes.
Serve as functional probes: Beyond their potential as inhibitors, these aptamers provide a method to probe the structure-function relationships and dynamics of essential translation factors, offering a "proof of concept" for using aptamers to study transient, essential reactions in protein synthesis that are difficult to capture with static structural methods.

The work highlights that perturbing a defined surface of IF2 (specifically the G and C1 domains) is sufficient to impair the correct progression of translation initiation, validating the potential of aptamers as precise molecular tools for dissecting the functional landscape of translation factors.

More like this